Nonalcoholic Fatty Liver Disease and the Development of Metabolic Comorbid Conditions in Patients With Human Immunodeficiency Virus Infection

Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

(2019) Peter J. Eddowes et al.   GASTROENTEROLOGY

Improvement in liver steatosis after the switch from a ritonavir-boosted protease inhibitor to raltegravir in HIV-infected patients with non-alcoholic fatty liver disease

(2019) Leonardo Calza et al.   Infectious Diseases

Vitamin E is an effective treatment for nonalcoholic steatohepatitis in HIV mono-infected patients

(2019) Giada Sebastiani et al.   AIDS

Application of guidelines for the management of nonalcoholic fatty liver disease in three prospective cohorts of HIV ‐monoinfected patients

(2019) G Sebastiani et al.   HIV MEDICINE

Predictors of chronic kidney disease and utility of risk prediction scores in HIV positive individuals

(2018) Emily L. Woolnough et al.   AIDS

Hypertension Canada’s 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children

(2018) Kara A. Nerenberg et al.   CANADIAN JOURNAL OF CARDIOLOGY

Definition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome

(2018) Zubin Punthakee et al.   Canadian Journal of Diabetes

Global Burden of Atherosclerotic Cardiovascular Disease in People Living with the Human Immunodeficiency Virus: A Systematic Review and Meta-Analysis

(2018) Anoop S. V. Shah et al.   CIRCULATION

Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis

(2018) Alessandro Mantovani et al.   DIABETES CARE

Incidence and Risk Factors for Prediabetes and Diabetes Mellitus Among HIV-infected Adults on Antiretroviral Therapy

(2018) Jobert Richie Nansseu et al.   EPIDEMIOLOGY

Nonalcoholic fatty liver disease incidence and impact on metabolic burden and death: A 20 year-community study

(2018) Alina M. Allen et al.   HEPATOLOGY

Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV-positive persons version 9.0

(2018) L Ryom et al.   HIV MEDICINE

Hypertension in HIV-Infected Adults

(2018) Sasha A. Fahme et al.   HYPERTENSION

Liver-related events in HIV-infected persons with occult cirrhosis

(2018) Amine Benmassaoud et al.   CLINICAL INFECTIOUS DISEASES

Introduction: Standards of Medical Care in Diabetes—2019

(2018)   DIABETES CARE

Diagnostic accuracy of noninvasive markers of steatosis, NASH and liver fibrosis in HIV-monoinfected individuals at-risk of non-alcoholic fatty liver disease (NAFLD)

(2018) Maud Lemoine et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Predictive factors associated with liver fibrosis and steatosis by transient elastography in patients with HIV mono-infection under long-term combined antiretroviral therapy

(2018) Hugo Perazzo et al.   Journal of the International AIDS Society

Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases

(2017) Leon A Adams et al.   GUT

Human immunodeficiency virus-infected and uninfected adults with non-genotype 3 hepatitis C virus have less hepatic steatosis than adults with neither infection

(2017) Jennifer C. Price et al.   HEPATOLOGY

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

(2017) Naga Chalasani et al.   HEPATOLOGY

Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis

(2017) Parambir S. Dulai et al.   HEPATOLOGY

Development of chronic kidney disease in patients with non-alcoholic fatty liver disease: A cohort study

(2017) Dong Hyun Sinn et al.   JOURNAL OF HEPATOLOGY

Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosis

(2017) Thomas Pembroke et al.   JOURNAL OF HEPATOLOGY

Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis

(2017) Thomas Karlas et al.   JOURNAL OF HEPATOLOGY

Nonalcoholic fatty liver disease diagnosed by transient elastography with controlled attenuation parameter in unselected HIV monoinfected patients

(2016) Élise Vuille-Lessard et al.   AIDS

2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult

(2016) Todd J. Anderson et al.   CANADIAN JOURNAL OF CARDIOLOGY

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

(2016) Zobair M. Younossi et al.   HEPATOLOGY

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

(2016)   JOURNAL OF HEPATOLOGY

Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance

(2016) Kuen Cheh Yang et al.   Scientific Reports

Transient elastography for the detection of hepatic fibrosis in HIV-monoinfected adults with elevated aminotransferases on antiretroviral therapy

(2015) Caryn G. Morse et al.   AIDS

HIV and chronic kidney disease

(2015) Saraladevi Naicker et al.   CLINICAL NEPHROLOGY

Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration

(2014) Colette J Smith et al.   LANCET

Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice Guideline

(2013) Paul E. Stevens   ANNALS OF INTERNAL MEDICINE

Cardiovascular Disease and HIV Infection

(2013) Virginia A. Triant   Current HIV/AIDS Reports

Noninvasive Methods to Assess Liver Disease in Patients With Hepatitis B or C

(2012) Laurent Castera   GASTROENTEROLOGY

Hepatic Steatosis in Human Immunodeficiency Virus

(2012) Richard K. Sterling et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Impact of NRTIs on lipid levels among a large HIV-infected cohort initiating antiretroviral therapy in clinical care

(2010) Heidi M Crane et al.   AIDS

Nonalcoholic Fatty Liver Disease Among HIV-Infected Persons

(2009) Nancy Crum-Cianflone et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus-1 mono-infected patients on antiretroviral therapy

(2008) Patrick Ingiliz et al.   HEPATOLOGY